European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)

De Backer, Guy, Ambrosioni, Ettore, Broch-Johnsen, Knut, Brotons, Carlos, Cifkova, Renata, Dallongeville, Jean, Ebrahim, Shah, Faergeman, Ole, Graham, Ian, Mancia, Guiseppe, Cats, Volkert Manger, Orth-Gom??r, Kristina, Perk, Joep, Py??r??l??, Kalevi, Rodicio, Jos?? L., Sans, Susana, Sansoy, Vedat, Sechtem, Udo, Silber, Sigmund, Thomsen, Troels, Wood, David·2003·European Journal of Cardiovascular Prevention & Rehabilitation

DOI 10.1097/00149831-200308000-00004

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1097/00149831-200308000-00004

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Self-citation
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
Self-citation
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
Self-citation
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus
Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., et al. (2007) · Diabetes Care · doi:10.2337/dc07-9917 · Cited by 1,055
Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries
Kotseva, K., Wood, D., De Backer, G., De Bacquer, D., Pyörälä, K., & Keil, U. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60330-5 · Cited by 833
Self-citation
EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries
Kotseva, K., Wood, D., Backer, G. D., Bacquer, D. D., Pyörälä, K., Keil, U., & EUROASPIRE Study Group (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3283294b1d · Cited by 812
Self-citation
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.028 · Cited by 706
Self-citation
Value and Limitations of Existing Scores for the Assessment of Cardiovascular Risk
Cooney, M. T., Dudina, A. L., & Graham, I. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.020 · Cited by 436
Self-citation
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study
Banegas, J. R., Lopez-Garcia, E., Dallongeville, J., Guallar, E., Halcox, J. P., Borghi, C., Masso-Gonzalez, E. L., Jimenez, F. J., Perk, J., Steg, P. G., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr080 · Cited by 354
Self-citation
Work-Related Psychosocial Factors and the Development of Ischemic Heart Disease: A Systematic Review
Eller, N. H., Netterstrøm, B., Gyntelberg, F., Kristensen, T. S., Nielsen, F., Steptoe, A., & Theorell, T. (2009) · Cardiology in Review · doi:10.1097/crd.0b013e318198c8e9 · Cited by 323
EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries
Kotseva, K., Wood, D., De Backer, G., De Bacquer, D., Pyörälä, K., Reiner, Ž., Keil, U., & EUROASPIRE Study Group (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3283383f30 · Cited by 238
Self-citation
Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands
Pijlman, A. H., Huijgen, R., Verhagen, S. N., Imholz, B. P. M., Liem, A. H., Kastelein, J. J. P., Abbink, E. J., Stalenhoef, A. F. H., & Visseren, F. L. J. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.09.014 · Cited by 238
Cardiovascular Risk-Estimation Systems in Primary Prevention: Do They Differ? Do They Make a Difference? Can We See the Future?
Cooney, M. T., Dudina, A., D'Agostino, R., & Graham, I. M. (2010) · Circulation · doi:10.1161/circulationaha.109.852756 · Cited by 222
Self-citation
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.012 · Cited by 192
Self-citation
Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: A systematic review and meta-analysis of prospective studies
Ye, X., Kong, W., Zafar, M. I., & Chen, L.-L. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0851-z · Cited by 138
Probably at-risk, but certainly ill — Advocating the introduction of a psychosis spectrum disorder in DSM-V
Ruhrmann, S., Schultze-Lutter, F., & Klosterkötter, J. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.03.015 · Cited by 147
Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology
Graham, I. M., Stewart, M., Hertog, M. G. L., & Forced, O. B. O. T. C. R. T. T. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000219112.02544.24 · Cited by 116
Self-citation
Effectiveness of nurse-delivered cardiovascular risk management in primary care: a randomised trial
Voogdt-Pruis, H. R., Beusmans, G. H., Gorgels, A. P., Kester, A. D., & Van Ree, J. W. (2010) · British Journal of General Practice · doi:10.3399/bjgp10x482095 · Cited by 114
Anxiety and depression after acute myocardial infarction: an 18-month follow-up study with repeated measures and comparison with a reference population
Hanssen, T. A., Nordrehaug, J. E., Eide, G. E., Bjelland, I., & Rokne, B. (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32832e4206 · Cited by 111
Hormone replacement therapy and cardiovascular disease: increased risks of venous thromboembolism and stroke, and no protection from coronary heart disease
Lowe, G. D. O. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01400.x · Cited by 54
Type D Personality and Mortality in Peripheral Arterial Disease: A Pilot Study
Aquarius, A. E. (2009) · Archives of Surgery · doi:10.1001/archsurg.2009.75 · Cited by 43
Examining Development Processes for Text Messaging Interventions to Prevent Cardiovascular Disease: Systematic Literature Review
Ricci-Cabello, I., Bobrow, K., Islam, S. M. S., Chow, C. K., Maddison, R., Whittaker, R., & Farmer, A. J. (2019) · JMIR mHealth and uHealth · doi:10.2196/12191 · Cited by 36
Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in Germany
Böhler, S., Scharnagl, H., Freisinger, F., Stojakovic, T., Glaesmer, H., Klotsche, J., Pieper, L., Pittrow, D., Kirch, W., Schneider, H., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.025 · Cited by 34
Self-citation
The Lipid Profile and Mortality Risk in Elderly Type 2 Diabetic Patients: A Ten-Year Follow-Up Study (ZODIAC-13)
van Hateren, K. J. J., Landman, G. W. D., Kleefstra, N., Logtenberg, S. J. J., Groenier, K. H., Kamper, A. M., Houweling, S. T., & Bilo, H. J. G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008464 · Cited by 34
Economic evaluation of primary prevention of cardiovascular diseases in mild hypertension: a scenario analysis for the Netherlands
Stevanović, J., O’Prinsen, A. C., Verheggen, B. G., Schuiling-Veninga, N., Postma, M. J., & Pechlivanoglou, P. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.01.008 · Cited by 12

Authors: De Backer, G., Ambrosioni, E., Broch-Johnsen, K., Brotons, C., Cifkova, R., Dallongeville, J., Ebrahim, S., Faergeman, O., Graham, I., Mancia, G., Cats, V. M., Orth-Gom??r, K., Perk, J., Py??r??l??, K., Rodicio, J. L., Sans, S., Sansoy, V., Sechtem, U., Silber, S., Thomsen, T., & Wood, D.
Venue: European Journal of Cardiovascular Prevention & Rehabilitation
Publisher: Oxford University Press (OUP)
Published: 2003-08
Volume: 10
Issue: 4
Pages: S1-S10
ISSN: 1741-8267 (ISSN-L)
DOI: 10.1097/00149831-200308000-00004
OpenAlex: W4298963798
Cited by: 440
References: 0
FWCI: 31.65
Type: journal article
Language: en
Open access: closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review